Pure Global

Circulating MrgD in Pulmonary Hypertension - Trial NCT06365372

Access comprehensive clinical trial information for NCT06365372 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06365372
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06365372
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Circulating MrgD in Pulmonary Hypertension
Circulating MrgD Change in Patients With Pulmonary Hypertension

Study Focus

Pulmonary Hypertension

Western blot

Observational

diagnostic test

Sponsor & Location

Qilu Hospital of Shandong University

Jinan, China

Timeline & Enrollment

N/A

Apr 10, 2024

Jun 01, 2024

90 participants

Primary Outcome

Circulating MrgD level

Summary

The aim of the study is to observe the change of the circulating MrgD level in patients with
 pulmonary hypertension compared with subjects without pulmonary hypertension.

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT06365372

Non-Device Trial